Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary L Johnson

Showing results (161-170 of 171) with videos related to

Pageof 18
Sort By:
Immunity|September 26, 2025
Intra-tumoral hypoxia promotes CD8<sup>+</sup> T cell dysfunction via chronic activation of integrated stress response transcription factor ATF4Coral Del Mar Alicea Pauneto, Brian P Riesenberg, Evelyn J Gandy, et al.
Cancer Research|February 24, 2018
Mass Spectrometry-Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast CancersFilip Mundt, Sandeep Rajput, Shunqiang Li, et al.
Plos One|June 14, 2018
Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2, Robert Allaway, Steve P Angus, et al.
NPJ Breast Cancer|May 13, 2021
FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036Steven P Angus, Timothy J Stuhlmiller, Gaurav Mehta, et al.
Nature Communications|July 10, 2025
PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2Marwah Karim, Manjari Mishra, Chieh-Wen Lo, et al.
Nature Medicine|January 14, 2021
Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trialMichael J Fisher, Chie-Schin Shih, Steven D Rhodes, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
The MEK inhibitor trametinib incurs mitochondrial injury and induces innate immune responses in the mouse heartKelsey H Fisher-Wellman, Richard D Lutze, Logan G Kirkland, et al.
Science Advances|July 10, 2026
The MEK inhibitor trametinib incurs mitochondrial injury and induces innate immune responses in the mouse heartKelsey H Fisher-Wellman, Richard D Lutze, Logan G Kirkland, et al.
Nature Reviews. Drug Discovery|February 24, 2018
Unexplored therapeutic opportunities in the human genomeTudor I Oprea, Cristian G Bologa, Søren Brunak, et al.
Nature Reviews. Drug Discovery|March 24, 2018
Unexplored therapeutic opportunities in the human genomeTudor I Oprea, Cristian G Bologa, Søren Brunak, et al.
Pageof 18

Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
Immunity|September 26, 2025
Intra-tumoral hypoxia promotes CD8<sup>+</sup> T cell dysfunction via chronic activation of integrated stress response transcription factor ATF4Coral Del Mar Alicea Pauneto, Brian P Riesenberg, Evelyn J Gandy, et al.
Cancer Research|February 24, 2018
Mass Spectrometry-Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast CancersFilip Mundt, Sandeep Rajput, Shunqiang Li, et al.
Plos One|June 14, 2018
Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2, Robert Allaway, Steve P Angus, et al.
NPJ Breast Cancer|May 13, 2021
FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036Steven P Angus, Timothy J Stuhlmiller, Gaurav Mehta, et al.
Nature Communications|July 10, 2025
PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2Marwah Karim, Manjari Mishra, Chieh-Wen Lo, et al.
Nature Medicine|January 14, 2021
Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trialMichael J Fisher, Chie-Schin Shih, Steven D Rhodes, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
The MEK inhibitor trametinib incurs mitochondrial injury and induces innate immune responses in the mouse heartKelsey H Fisher-Wellman, Richard D Lutze, Logan G Kirkland, et al.
Science Advances|July 10, 2026
The MEK inhibitor trametinib incurs mitochondrial injury and induces innate immune responses in the mouse heartKelsey H Fisher-Wellman, Richard D Lutze, Logan G Kirkland, et al.
Nature Reviews. Drug Discovery|February 24, 2018
Unexplored therapeutic opportunities in the human genomeTudor I Oprea, Cristian G Bologa, Søren Brunak, et al.
Nature Reviews. Drug Discovery|March 24, 2018
Unexplored therapeutic opportunities in the human genomeTudor I Oprea, Cristian G Bologa, Søren Brunak, et al.
Pageof 18